Analgesics (Pharmacies) - Fiji

  • Fiji
  • Revenue in the Analgesics market is projected to reach US$0.77m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.59%, resulting in a market volume of US$1.11m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.81 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Fiji is experiencing steady growth due to several factors.

Customer preferences:
Customers in Fiji have shown a growing preference for analgesics purchased from pharmacies rather than other retail outlets. This is primarily due to the trust and reliability associated with pharmacies, as well as the convenience of being able to seek advice from trained pharmacists. Additionally, customers in Fiji tend to prioritize quality and safety when it comes to healthcare products, making pharmacies their preferred choice for purchasing analgesics.

Trends in the market:
One major trend in the Analgesics (Pharmacies) market in Fiji is the increasing demand for over-the-counter (OTC) analgesics. This trend can be attributed to the rising awareness among consumers about self-medication and the ease of access to OTC products in pharmacies. Customers are increasingly seeking quick relief from minor pain and discomfort, and OTC analgesics provide a convenient solution. Another trend in the market is the growing demand for natural and herbal analgesics. This trend is driven by the increasing popularity of natural remedies and the perception that they are safer and have fewer side effects compared to synthetic analgesics. Customers in Fiji are increasingly seeking alternatives to traditional analgesics, and pharmacies are responding to this demand by expanding their range of natural and herbal analgesics.

Local special circumstances:
Fiji is an island nation with a unique healthcare system that is heavily reliant on pharmacies. Due to the geographical distribution of the population, pharmacies are often the most accessible healthcare providers for many Fijians. This has created a strong demand for pharmaceutical products, including analgesics, in the country. Additionally, pharmacies in Fiji play a crucial role in providing healthcare advice and services, making them an integral part of the healthcare ecosystem.

Underlying macroeconomic factors:
Fiji has experienced steady economic growth in recent years, which has contributed to the growth of the Analgesics (Pharmacies) market. As the economy improves, consumers have more disposable income to spend on healthcare products, including analgesics. This has led to an increase in the demand for analgesics in pharmacies. Furthermore, the government of Fiji has made healthcare a priority, investing in the development of healthcare infrastructure and promoting access to healthcare services. This has created a favorable environment for the growth of the Analgesics (Pharmacies) market in Fiji, as pharmacies are able to provide affordable and accessible healthcare products to the population. In conclusion, the Analgesics (Pharmacies) market in Fiji is growing steadily due to customer preferences for pharmacy purchases, the increasing demand for OTC and natural analgesics, the unique circumstances of the healthcare system in Fiji, and the underlying macroeconomic factors of economic growth and government investment in healthcare.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)